baber/WOPTO huggingface dataset:
Patent JP-4041214-B2 (JP)
IPC: F16D65/28
Filed: 1998-05-26
Granted: 2008-01-30
Abstract: PROBLEM TO BE SOLVED: To increase the braking force without providing the force increasing mechanism, by providing two operation chambers in series in a chamber, in an air type unit brake device installed to a railroad rolling stock. SOLUTION: This air type unit brake device has an air chamber 100 installed to a carriage side, and a rod 40 is pressed out in the direction C of the arrow to press a brake shoe installed to the rod 40 to a wheel, so as to generate a braking force. Inside the air chamber 100, the first operation chamber 104 and the second operation chamber 108 are provided in series. The second shaft 130 is supported rotatable to the first shaft 114, and the second operation chamber 108 presses out the second shaft 130 by fitting to the thrust of the first operation chamber 104. Between the rod 40 and the second shaft 130, an adjuster device to regulate the clearance between a brake shoe 70 and a wheel 5 automatically is provided.
Patent JP-H0233348-B2 (JP)
IPC: A23K1/16
Filed: 1981-09-21
Abstract: Supplemented livestock feedstuffs and methods of feeding using as active ingredient a chemical compound having histamine H2 antagonist activity improve the utilization of food by meat producing animals. A specific compound of use as the active ingredient is metiamide.
Patent JP-2644431-B2 (JP)
IPC: H05B6/10
Filed: 1993-06-30
Granted: 1997-08-25
Abstract: An induction coil for joining structural members by heating a bonding material disposed between the structural members. The induction coil includes first and second elements disposed in a non-parallel arrangement adjacent one surface and along one side edge of two juxtaposed structural members. In one embodiment, the first and second elements are joined together at adjacent ends. A base and a riser are connected to intermediate spaced ends of the first element for attaching the induction coil to a source of high frequency electrical current. The first and second elements, the base and the riser are formed of hollow, tubular members to form a coolant flow path therethrough.
Patent JP-3001063-B2 (JP)
IPC: B22D11/04
Filed: 1990-07-19
Granted: 2000-01-17
Abstract: The subject of the present invention is a plate mould for continuous casting of metal, comprising four cooled plates (2, 3) delimiting between them a cavity (4) whose corners are cut by bevels (9) and in which the plates (3) of each pair of opposite plates bear on corresponding bearing faces (8) of the plates (2) of the other pair of opposite plates, the plates (2, 3) being intended to be clamped against one another by clamping devices (10) acting virtually perpendicularly to the bearing faces (8). 
<??>According to the invention, the bevel (9) of each corner of the cavity (4) is formed by the hypotenuse of a right-angled triangle of which the sides of the right angle are each located in a plane formed by the inner wall of one of the adjacent plates (2, 3) and have a length greater than 30 mm. 
<IMAGE>
Patent JP-3158199-B2 (JP)
IPC: F16F15/10
Filed: 1991-07-11
Granted: 2001-04-23
Abstract: This device employs a viscoelastic material (8) which dissipates the energy of vibration via a coupling means. According to the invention, the viscoelastic material (8) is first arranged and fixed to a support member (7) to form a single removable assembly that can be coupled to the emitter (1) by its own means. The device also comprises a pressure component (9) which, together with the support member (7), clamps the viscoelastic material (8). Application to sound-proofing materials. <IMAGE>
Patent JP-H0236124-B2 (JP)
IPC: B01J39/20
Filed: 1982-11-19
Abstract: The invention relates to new reticulated statistic acrylic copolymers that may be used in a very wide range of solvents (water, methylene chloride, chloroform, methanol, ethanol, dimethylformamide, pyridine,) stable between pH 1 and pH 14, to preparation process thereof and to their use in ion exchange chromatography.
Patent JP-3945842-B2 (JP)
IPC: C12N7/00
Filed: 1996-08-01
Granted: 2007-07-18
Abstract: The present invention provides the novel Newcastle disease virus strain C2 which is able to induce a solid immune response in poultry without adverse vaccination reactions.
Patent JP-3060434-B2 (JP)
IPC: H01L23/31
Filed: 1993-08-19
Granted: 2000-07-10
Abstract: A method of obtaining high quality passivation layers on silicon carbide surfaces by oxidizing a sacrificial layer of a silicon-containing material on a silicon carbide portion of a device structure to substantially consume the sacrificial layer to produce an oxide passivation layer on the silicon carbide portion that is substantially free of dopants that would otherwise degrade the electrical integrity of the oxide layer. The oxidizing of the sacrificial layer is preferably achieved by thermal oxidizing. The silicon carbide portion may be of p-type silicon carbide which is aluminium doped. <IMAGE>
Patent JP-3932543-B2 (JP)
IPC: C08G73/06
Filed: 1998-08-21
Granted: 2007-06-20
Abstract: PROBLEM TO BE SOLVED: To obtain a polyamic acid good in liquid crystal aligning when made into a liquid crystal film, and useful as a liquid crystal aligning agent with a wide pretilt angle by reaction between a specific tetracarboxylic acid dianhydride and a specific diamine compound. SOLUTION: This polyamic acid is obtained by reaction between (A) a tetracarboxylic acid dianhydride including a compound of formula I (R1 is a 5-30C alkyl, halogen, 1-30C haloalkyl or a univalent organic group having steroidal skeleton; X is a single bond or bivalent bond group; R2 and R3 are each H or a univalent organic group; (a) is 1-4; (b) is 0-3) and (B) a diamine compound of the formula H2N-R4-NH2 (R4 is a bivalent organic group). By the way, the compound of formula I is prepared by ene reaction between maleic anhydride and the reaction product formed by Diels-Alder reaction between maleic anhydride and a styrene derivative of formula II.
Patent JP-4200392-B2 (JP)
IPC: B32B27/18
Filed: 1997-08-26
Granted: 2008-12-24
Abstract: Molecular complex compounds (I) of a mono-, bis- or tris-acylphosphine oxide compound (II) with an  alpha -hydroxyketone compound (III) are new. Also claimed are (a) photopolymerisable compositions containing ethylenically unsaturated polymerisable compound(s) and (I) as photoinitiator; (b) a method for photopolymerisation of such compositions; (c) substrates coated with the composition; and (d) the photographic production of reliefs by selective exposure of the coated substrate and removing the unexposed areas with a solvent.
Patent JP-3863645-B2 (JP)
IPC: G01N33/543
Filed: 1997-09-17
Granted: 2006-12-27
Abstract: A process of manufacturing test strips of the type comprising a length of porous carrier material capable of acting as a liquid flow path for a sample liquid and having at least zone downstream from a first end of the strip which zone contains an immobilised specific binding agent to act as a capture means during an assay to reveal the presence of an analyte in applied sample liquid, and in which process the specific binding agent is deposited onto a sheet of the porous carrier material which is then blocked and subdivided into a plurality of individual identical test strips, wherein blocking of the porous carrier material is achieved by applying a solution of blocking agent to the sheet upstream from the zone in an amount sufficient to ensure that the solution permeates downstream to beyond the zone. Preferably there is a plurality of zones of immobilised agent arranged in series on the strip, and wherein blocking is achieved by applying a solution of blocking agent to the sheet upstream from the first of the plurality of zones in an amount sufficient to ensure that the solution permeats downstream to beyond the last of the plurality of zones. <IMAGE>
Patent JP-2542362-B2 (JP)
IPC: A61P15/00
Filed: 1985-11-12
Granted: 1996-10-09
Abstract: Synthetic nonapeptide and decapeptide LHRH antagonist analogs having a halo lower alkyl guanadino-substituted amino acyl residue at position six are disclosed herein.
Patent JP-3229176-B2 (JP)
IPC: H01L23/02
Filed: 1995-10-05
Granted: 2001-11-12
Abstract: PROBLEM TO BE SOLVED: To provide a radiation-proof package which can be maintained in a highly reliable state for a long period and can prevent the deterioration of a semiconductor element by secondary radiation by providing an airtightly sealed inner package housing a substrate mounted with a hybrid IC and an outer package housing the inner package and composed of a radiation shielding material. SOLUTION: A ceramic substrate or metallic plate 2 mounted which a hybrid IC 1 composed of an integrated circuit and an electronic section is set on an inner package base 3a. External lead pins 5 which are electrically connected to the substrate 2 through bonded wires 4 are lead out from holes formed through the side faces of the base 3a and the clearances. between the base 3a and the pins 5 are airtightly sealed with hermetic glass 6. The inner package 3 is housed in an outer package 7 composed of an outer package base 7a composed of a tungsten allay and an outer package cover 7b which is the lid of the base 7a.
Patent JP-2714546-B2 (JP)
IPC: A61K6/884
Filed: 1995-10-25
Granted: 1998-02-16
Abstract: 2-methylene-1,3-dioxepane derivs. of formula (I) are new. m, n and p = 0 or 1; U and V = O or (CH2)q; q = 0 - 3; R, R1 and R2 = H or alkyl, alkenyl, aryl or alicyclic gps. opt. substd. by alkyl, vinyl, (meth)acryloyl, (meth)acryloyloxy, COOR3, CONR3R3 or OR3, or one may be linked to another 2-methylene-1,3-dioxepane ring, or R1+R2 = CH2.
Patent JP-3382684-B2 (JP)
IPC: D04B9/42
Filed: 1993-10-12
Granted: 2003-03-04
Abstract: Method for joining two edges of a knitted tubular manufactured product, particularly a stocking (hose), including the phase of manufacturing a manufactured product with a circular machine with just one cylinder, starting with the elastic edge and ending on the side of the tip which remains open, which method envisages:   (a) raising a predetermined number of needles (3) of a first half-row; (b) subsequently raising the said needles (3) to allow the corresponding stitches (8) to be taken up; (c) raising to the same level a predetermined number of needles (7) with the stitches (80) of the second half-row;   (d) taking up the said stitches (8);   (e) lowering the said needles (3) of the first half-row; (f) transferring the stitches (8) thus taken up onto the corresponding needles (7) of the second half-row, turning them over (turning them round, twisting them);   (g) raising the needles (7) of the second half-row; (h) locating the superimposed pairs of stitches (8, 80) of each needle (7) of the second half-row strictly juxtaposed and coaxial;   (i) subsequently raising the needles (7) of the second half-row; (l) turning the needle cylinder (1) with an intermittent movement and, in each step, inserting a mending-in (grafting, linking) needle (9) into a pair of stitches thus raised, supplying it with some thread (F) used for knitting the manufactured product, without a break in continuity, and then extracting it in order to form a mending-in (grafting) stitch; (m) after making the last mending-in stitch, making two or more than two closure knots (I, II);   (n) cutting the thread (F); (o) lowering the needles (7) of the second half-row until the threads are taken down from the hooks.   <IMAGE>
Patent JP-4260936-B2 (JP)
IPC: B05B5/10
Filed: 1998-10-09
Granted: 2009-04-30
Abstract: A high magnitude potential supply comprising a first circuit for generating a first signal related to a desired output high magnitude potential across a pair of output terminals of the supply, a second circuit for generating a second signal related to an output current from the high magnitude potential supply, a third circuit for supplying an operating potential to the high magnitude potential supply so that it can produce the high magnitude operating potential, the third circuit having a control terminal, a fourth circuit coupled to the first and second circuits and to the control terminal, the fourth circuit receiving the first and second signals from the first and second circuits and controlling the operating potential supplied to the high magnitude potential supply by the third circuit, and a fifth circuit for disabling the supply of operating potential to the high magnitude potential supply so that no high magnitude operating potential can be supplied by it, the fifth circuit also coupled to the control terminal. <IMAGE>
Patent JP-2512173-B2 (JP)
IPC: F04D7/04
Filed: 1989-11-08
Granted: 1996-07-03
Abstract: A fluidizing centrifugal pump (10) for medium to high consistency fiber suspension includes a housing (14) having an inlet channel (16) and an outlet (18) and an impeller (12) operatively rotatable about the pump axis (34). The impeller (12) has a working vane (36) and at least a blade (40) extending substantially axially from the working vane (36) and disposed in the inlet channel (16) for fluidizing suspension which is received in the pump inlet (16). A feeding (44) vane, preferably in the form of a spiral thread, is disposed in the inlet channel (16), radially-outwardly from the fluidizing blade (40) and extending along at least a portion of the axial extension of the blade (40). The feeding vane (44), which may be operatively rotatable with the impeller (12) or stationarily fixed to the pump housing (14), provides axially-directed feeding of suspension through the inlet channel (16) toward the working vanes (36), concurrent with fluidizing of suspension in the channel (16) by the impeller blade (40), thereby effectively preventing reverse flow of suspension in the inlet channel (16) and correspondingly increasing the operating efficiency of the centrifugal pump (10).
Patent JP-H0819106-B2 (JP)
IPC: C09K11/07
Filed: 1988-12-16
Abstract: New acridinium compounds are provided which comply with formula 1, wherein  A is a divalent organic moiety, such as an alkylene chain, X is a group which can be transformed together with C-9 of the acridine into a dioxetane by reaction with hydrogen peroxide, such as an aryloxy group,  Y is a counter ion, and  Z is a functional group, such as a carboxyl derivative. These acridinium compounds are useful as chemiluminogenic labels for both heterogeneous and homogeneous immunoassays.
Patent JP-H0569696-B2 (JP)
Inventor: KAARU HEERU
IPC: B29C45/67
Filed: 1987-12-21
Abstract: A hydraulic actuator assembly for use in a mold clamping unit of an injection molding machine. The actuator assembly serves as a rapid-travel drive for mold opening and closing movements and as a source of elevated mold clamping pressure. Among the hydraulic elements contributing to the operation of the mold clamping unit are a power piston for effecting elevated mold clamping pressures and a drive piston for effecting rapid die closing movements. With the hydraulic actuator system of the present invention, it is possible to control the operation of the mold clamping unit based on two-sided hydraulic influencing of the power piston and the drive piston.
Patent JP-3264958-B2 (JP)
IPC: B29C48/71
Filed: 1991-12-11
Granted: 2002-03-11
Abstract: Multilayer films are generated by dividing a first stream comprised of discrete layers of one or more materials into a plurality of branch streams (14,16,18,20), redirecting or repositioning (40) the branch streams, expanding (48) and contracting (54) the branch streams in a symmetrical fashion, and recombining (56) the branch streams to form a second stream having a greater number of discrete layers than the first stream. Alternatively, the branch streams are redirected or repositioned (64), recombined (68) to form a second stream having a greater number of discrete layers than the first stream, and the second stream expanded and contracted (66) in a symmetrical fashion. A gradient in, or other distribution of, thickness is provided by independently controlling (58,60) the flow rates of the branch streams. <IMAGE>
Patent JP-3452566-B2 (JP)
IPC: G02B7/00
Filed: 1990-12-10
Granted: 2003-09-29
Abstract: PCT No. PCT/GB90/01920 Sec. 371 Date May 15, 1992 Sec. 102(e) Date May 15, 1992 PCT Filed Dec. 10, 1990 PCT Pub. No. WO91/09300 PCT Pub. Date Jun. 27, 1991.Apparatus as described by which very low light levels emitted typically by very small regions such as individual cells in cultured monolayers, can be more readily detected by a detector such as a CCD detector or image intensifier. The light capturing aid is a fibre optic face plate located between the light emitting material and the detector, but not in contact with the light emitting material. Where the latter is contained on a surface such as a petri dish, the face plate is positioned between the dish and the detector with at least an air gap between the face plate and the detector.
Patent JP-2625258-B2 (JP)
IPC: A61K31/38
Filed: 1992-06-17
Granted: 1997-07-02
Abstract: A compound represented by formula I Ar1-O-M-O-Ar2   I    wherein Ar1 and Ar2 are independently substituted phenyl or substituted pyridinyl, the substituents on said phenyl or pyridinyl being independently selected from one, two or three of (C1-C10) alkyl, (C1-C10) alkoxy, halogen, carbamyl, dialkylcarbamyl, (C1-C10)-alkoxycarbonyl, oxazoyl, and (C1-C10) alkyl substituted by halogen, (C1-C10) alkoxy, hydroxy, or (C1-C10) alkoxycarbonyl; <CHEM>     (C4-C8) alkylene, (C4-C8) alkenylene or     (C4-C8)- alkynylene;     O is oxygen;     R min  is (C1-C3) alkyl or H;     A is oxygen or sulfur; Q is selected from hydrogen, halogen, nitro, (C1-C6) alkyl, (C1-C6) perhaloalkyl, (C1-C6) alkylthio (C1-C6) alkyl sulfonyl; the dotted lines in M-3 and M-4 between carbons 2, 3 and 4, and 5 and 6 mean that the bonds between carbons 2 and 3, and 3 and 4, and 5 and 6, may each be a single or double bond;     n = 1 or 2     m = 1 or 2     p = 0 or 1 and     or pharmaceutically acceptable salts thereof. as well as pharmaceutical compositions containing the compounds and the use of the compounds of formula I for preparation of a medicament for methods of treating or preventing viral infections, especially picornaviral infections, are disclosed.
Patent JP-H0439877-B2 (JP)
IPC: B26B15/00
Filed: 1986-02-28
Abstract: PCT No. PCT/DE86/00076 Sec. 371 Date Oct. 22, 1986 Sec. 102(e) Date Oct. 22, 1986 PCT Filed Feb. 28, 1986 PCT Pub. No. WO86/05138 PCT Pub. Date Sep. 12, 1986.In a device for trimming, cutting out and cutting wallpaper particularly wallpaper of any kind which has just been applied, a knife carrying out upward and downward movements and a stationary resiliently resting knife with specially formed cutting edges are installed in a multipart housing. Furthermore, in this wallpaper cutting device the two knives projecting from the housing are effectively and safely protected and covered by a covering part connected to a trigger part. For the substitution of worn out and used up parts, as knives and batteries, the housing parts of the easily, without difficulty manageable wallpaper cutting device can be easily separated from each other without the use of additional tools.
Patent JP-H0379908-B2 (JP)
IPC: G10L25/78
Filed: 1987-03-18
Abstract: Speech signal-produced peak-values of speech levels and speech signal-produced minimum-values of speech levels are recorded in such a way that, after recording of a peak value or minimum value, this value is gradually reduced or increased until a new peak value exceeds the instantaneous recording threshold or a new minimum value falls below the instantaneous recording threshold. From the relevant current peak-value recording threshold values or minimum-value recording threshold values, a level regulation value is obtained by an adjustable reduction or increase, whereby the two level regulating values are combined together to form a level threshold value.
Patent JP-4211894-B2 (JP)
IPC: A61L26/00
Filed: 1995-07-14
Granted: 2009-01-21
Abstract: PCT No. PCT/BE95/00069 Sec. 371 Date Jul. 7, 1997 Sec. 102(e) Date Jul. 7, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02571 PCT Pub. Date Feb. 1, 1996A fibrinogen concentrate has a purity of 98% or higher and is free of viral contaminants and proteases. The fibrinogen concentrate is obtained by subjecting a solubilized plasma fraction containing fibrinogen to a viral inactivation chemical treatment using a solvent/detergent, subjecting the resulting viral-inactivated fraction to precipitation in a solution containing an amino acid at an acidic pH to obtain a supernatant, filtering the supernatant to obtain a purified fibrinogen concentrate, and recovering the purified fibrinogen concentrate.
Patent JP-H0661246-B2 (JP)
IPC: A23C19/10
Filed: 1990-02-02
Abstract: Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth in a product comprises adding to the product a safe and effective amount of an active form of CLA. Active forms of CLA include 9,11-octadecadoenoic acid, 10,12-octadecadienoic acid, active isomers thereof, non-toxic salts thereof; active esters; other active chemical derivatives thereof, and mixtures thereof. Simple methods of making the compositions and novel compositions are also disclosed.
Patent JP-2540576-B2 (JP)
IPC: C07H19/04
Filed: 1987-07-02
Granted: 1996-10-02
Abstract: Use of a compound of the formulawherein Base is thymine, Cytosine, adenine or guanine, or a physiologically acceptable salt thereof, for therapeutic or prophylactic control or treatment of retrovirus infections, including HIV, and hepatitis B virus infections and to a method for such treatment, especially for AIDS.
Patent JP-2986549-B2 (JP)
IPC: A61K48/00
Filed: 1994-07-20
Granted: 1999-12-06
Abstract: An alteration in phosphorylation of serine 105, within the activation domain ofNF-IL6/LAP, alters its transcription efficacy. Polypeptides, polynucleotides and methods of use for modified transcriptional activators allow regulation of gene expression. The Figure shows CAT activity for HepG2 cells co-transfected with a CAT reporter plasmid and pCMV-LAP(wt), pCMV-LAP(A1a105), and pCMV-LAP(Asp) plasmids.
Patent JP-3048387-B2 (JP)
IPC: C07K19/00
Filed: 1993-07-29
Granted: 2000-06-05
Abstract: Methods for the recombinant expression and secretion of viral proteins are disclosed. The methods involve the use of compatible escorts to shuttle the proteins to the cell surface. In this way, egress of recombinantly produced proteins out of the cell is facilitated, resulting in increased yields and easier purification of the desired protein.
Patent JP-3553616-B2 (JP)
IPC: C07K14/74
Filed: 1998-06-26
Granted: 2004-08-11
Abstract: Plasma EPCR has been isolated, characterized and shown to block cellular protein C activation and APC anticoagulant activity. Plasma EPCR appears to be about 43,000 daltons and circulates at approximately 100 ng/ml (98.4+/-27.8 ng/ml, n=22). Plasma EPCR bound activated protein C with an affinity similar to that of recombinant soluble EPCR (Kdapp approximately 30 nM), and inhibits both protein C activation on an endothelial cell line and APC anticoagulant activity in a one-stage factor Xa clotting assay. Soluble plasma EPCR appears to attenuate the membrane-bound EPCR augmentation of protein C activation and the anticoagulant function of activated protein C. Soluble EPCR has also been detected in urine. Levels of soluble EPCR can rise in inflammatory disease associated with vascular injury and appear to be correlated with inflammation and disease states associated with abnormal coagulation. Since EPCR expression is restricted to larger vessels and is usually negative in cappillaries, these observations provide a mechanism for analyzing injury/stimulation of large vessel endothelial cells.
Patent JP-3225040-B2 (JP)
IPC: H05K1/03
Filed: 1991-04-15
Granted: 2001-11-05
Abstract: Fluorinated polyether compositions having reactive end groups, such as formula (I) can be crosslinked to produce cured films useful as dielectrics for microelectronic applications. Other reactive end groups such as allyl, benzocyclobutyl, N-phenylmaleimido, alkynylphenyl, styryl, allylphenyl, cyanophenyl, and triazenophenyl are also suitable.